share_log

綠葉製藥:自願性公告 - 創新抗體藥物BA1106在中國獲批進行臨床試驗

LUYE PHARMA: VOLUNTARY ANNOUNCEMENT - APPROVAL OBTAINED FOR INITIATING CLINICAL TRIAL FOR THE INNOVATIVE ANTIBODY DRUG BA1106 IN CHINA

Sep 7, 2022 10:00
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more